Showing results (211-220 of 410) with videos related to

Sort By:
Pageof 41
Oncology Reports|May 25, 2011
Molecular-cloning of the human cycg1 gene encoding a g-type cyclin - overexpression in human osteosarcoma cellsL Wu, L Liu, A Yee, et al.
Journal of Cellular Physiology|January 1, 1996
Functional characterization of prostaglandin E2 inducible osteogenic colony forming units in cultures of cells isolated from the neonatal rat calvariumL Y Tang, D B Kimmel, W S Jee, et al.
Journal of Biomolecular NMR|October 14, 2005
Optimization of resolution and sensitivity of 4D NOESY using multi-dimensional decompositionT Luan, V Jaravine, A Yee, et al.
Surgical Innovation|October 24, 2008
Bone anchor mesh fixation for complex laparoscopic ventral hernia repairJ A Yee, K L Harold, W S Cobb, et al.
American Journal of Clinical Oncology|October 1, 1986
High-dose mitomycin-C with autologous bone marrow transplantation in patients with refractory malignancies. Influence of dose schedule on pharmacokinetics and nonhematopoietic toxicitiesC Karanes, V Ratanatharathorn, R B Schilcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup StudyM K Samson, L P Wasser, E C Borden, et al.
Cytometry|January 1, 1993
DNA content parameters of paraffin-embedded soft tissue sarcomas: optimization of retrieval technique and comparison to fresh tissueM M Zalupski, Z Maciorowski, J R Ryan, et al.
Cancer Treatment Reports|October 1, 1980
Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot studyL P Leichman, L H Baker, C R Stanhope, et al.
Investigational New Drugs|January 1, 1990
Phase II trial of intravenous melphalan for metastatic colorectal carcinoma. A Southwest Oncology Group studyW A Knight, P Goodman, S A Taylor, et al.
Investigational New Drugs|January 1, 1983
Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast. A Southwest Oncology Group studyF E Smith, N Gad-el-Mawla, B Tranum, et al.
Pageof 41